NCT02958657

Brief Summary

This project aims to evaluate, in recent post-acute myocardial infarction (AMI) patients on dual antiplatelet therapy, the impact of regular exercise training on platelet aggregability and the correlation between the level of platelet aggregability and muscle sympathetic nerve activity (MSNA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2016

Completed
Same day until next milestone

Study Start

First participant enrolled

October 30, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 8, 2016

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2019

Completed
Last Updated

April 2, 2021

Status Verified

March 1, 2021

Enrollment Period

2.4 years

First QC Date

October 30, 2016

Last Update Submit

March 30, 2021

Conditions

Keywords

Platelet functionAutonomic Nervous SystemMultiplate® (Multiple Electrode Aggregometry - MEA)VerifyNow®

Outcome Measures

Primary Outcomes (1)

  • Platelet aggregability by VerifyNow-P2Y12®

    To measure in recent post-AMI patients on dual antiplatelet therapy the impact of 03 months of regular exercise training (starting 30 days after the AMI) on platelet aggregability, analyzed by VerifyNow-P2Y12® test.

    Before the second CPET (04 months pot-AMI)

Secondary Outcomes (5)

  • Platelet aggregability by Multiplate-ADP®

    After the first CPET (01 month post-AMI)

  • Platelet aggregability by Multiplate-ASPI®

    After the first CPET (01 month post-AMI)

  • Platelet aggregability by Multiplate-ADP®

    After the second CPET (04 months post-AMI)

  • Platelet aggregability by Multiplate-ASPI®

    After the second CPET (04 months post-AMI)

  • Sympathetic activity by MSNA

    Before the second CPET (04 months post-AMI)

Study Arms (2)

Exercise Training

EXPERIMENTAL

Patients randomized to the training group will start the supervised regular training program 01 month after the myocardial infarction, and it will last for three months.

Other: Exercise Training

Control Group

NO INTERVENTION

Patients in the control group will receive general instructions regarding rehabilitation post-acute myocardial infarction and will be followed for four months after the myocardial infarction.

Interventions

Supervised exercise training program that includes two workouts per week for three months at a rehabilitation unit.

Also known as: Physical Activity, Physical Training, Rehabilitation
Exercise Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalization for spontaneous STEMI or non-STEMI in patients older than 18 years.

You may not qualify if:

  • Any condition that contraindicate physical activity;
  • Regular exercise training practitioners prior to the ischemic event;
  • Planned revascularization in the following 4 months;
  • Hospitalization for cardiovascular events in the previous 12 months;
  • Ventricular dysfunction, defined as left ventricular ejection fraction (LVEF) \<45% on echocardiography, evaluated by Simpson's method);f) Killip class III and IV;
  • High risk of arrhythmia and/or second and third degree atrioventricular block;
  • Diabetes mellitus requiring intravenous insulin therapy during hospitalization;
  • Important chronic kidney disease, defined by creatinine clearance\<30ml/min/m2 (estimated by MDRD formula);
  • Oral anticoagulation;
  • Use of NSAIDs and/or dipyridamole;
  • Contraindication to dual antiplatelet therapy;
  • Serum hemoglobin level \<10 g/dL;
  • Use of glycoprotein IIB/IIIA inhibitors in the last 48 hours;
  • Terminal illness;
  • Liver disease or coagulopathy;
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heart Institute of University of Sao Paulo Medical School

São Paulo, São Paulo, 05403-900, Brazil

Location

Related Publications (1)

  • Dalcoquio TF, Alves Dos Santos M, Silva Alves L, Bittar Brito Arantes F, Ferreira-Santos L, Pinto Brandao Rondon MU, Furtado RHM, Gehlen Ferrari A, Genestreti Rizzo PR, Salsoso R, Franci A, Moreira Baracioli L, de Nazare Nunes Alves MJ, Negrao CE, Nicolau JC. Effects of exercise on platelet reactivity after myocardial infarction: a randomized clinical trial. Platelets. 2023 Dec;34(1):2139821. doi: 10.1080/09537104.2022.2139821. Epub 2022 Nov 14.

MeSH Terms

Interventions

ExercisePhysical Conditioning, HumanRehabilitation

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Talia F Dalçóquio, MD

    Heart Institute (InCor) University of Sao Paulo Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 30, 2016

First Posted

November 8, 2016

Study Start

October 30, 2016

Primary Completion

March 31, 2019

Study Completion

March 31, 2019

Last Updated

April 2, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations